The stock is ripping hard at the moment so i thought it worth considering what the upside case is here...
Here a two ways I think ofit:
1: Top downmethod
- Legal cannabis sales in the US are currently $16bn (as recently quoted by Jeffries investment bank)
- They assume 50% of this is 'therapeutic' versus 'recreational'
- Of that $8bn, one might assume at least 50% is used to manage 'pain' (other uses being anxiety and sleep)
- That suggests a market size in the US only of >$4bn for 'pain'
- Since MDC's Nanabis product is the only cannabis product currently scheduled for Phase 3 FDA trails for 'pain', it could be a very large part of this market. Particularly assuming that any doctor would effectively be obliged to prescribe Nanabis in place of any other non-approved drug.
2: Comparison toGW Pharma (GWPH)
- The best global comp for what MDC could be in 5 years time is GWPH
- Citi values GWPH at US$5.95bn, as per the Sum-Of-Parts valuation below
- GWPH's core product, Epidiolex, is the only FDA approved cannabis product globally. However, it is only approved for use in Epilepsy, not pain or anxiety. It currently is doing $400m turnover per annum, but Citi has it forecast it to do around $1.6bn in 2025 - see below.
- The question is, what would MDC be worth if it were the only cannabis product with FDA approval for 'pain', which is a much, much larger market than epilepsy? Something larger than US$5.95bn??? It seems crazy, but go back and have a look at their Phase 2 trial results for MDC… they were very promising
- Forums
- ASX - By Stock
- How big could MDC be? Answer: Stupid big
The stock is ripping hard at the moment so i thought it worth...
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable